Are you involved in biomedical research and interested in starting your own company? Would you like to learn about the career options in healthcare beyond academia? Would you like to hear about the experiences of others who have already chosen this path?
Biocat organizes the “Claus per Bioemprendre” introductory course in bioentrepreneurship to share the personal experiences of top bioentrepreneurs in Catalonia with students and researchers.
The course has three three-hour sessions, covering the role of entrepreneurship in biotechnology; the first steps in bioentrepreneurship, from concept to first rounds of funding; and the phases and partners that make up the life cycle of a biotechnology company. ¨Claus per Bioemprendre¨ 8th edition will take place in three sessions held on May 15, 22 and 29, 2018. The deadline for registration is May 11.
The biotechnology company is an instrument that allows to advance a technology and transfer it to the market. Along the way appear different types of partners that accompany the project during a stage of it. This session shows how to align the interests of all travel companions to make it a successful business and technology project.
Tuesday, May 15, from 6:00 p.m. to 9:00 p.m.
6:00 – 6:30pm Registration and welcome
6:30 – 8:00pm Presentations
Lluís Pareras, Director of HealthEquity SCR
Montserrat Vendrell, Partner of Alta Life Sciences
Ignasi Costas, Partner of RCD-Rousaud Costas Duran
Jordi Naval, Director of Strategy of Biocat (Moderator)
8:00 – 8:15pm Round table
8:15 – 9.00pm Cocktail networking
2nd session "Claus per Bioemprendre": 'The first steps: from the idea to the first rounds of financing'
3rd session "Claus per Bioemprendre": 'Life cycle of the biotechnology company: steps and partners that will accompany us along the way'
For questions & further information, please send an e-mail to Anna Rovira (events@biocat.cat) or feel free to call us (+34 93 310 33 69).
Organizer
|
Collaborators
|
|
Sponsor
With the support of:
* With the support of the Department of Enterprise and Knowledge and the co-financing of the ESF
